tiprankstipranks
Trending News
More News >
Sareum Holdings PLC (GB:SAR)
LSE:SAR
Advertisement

Sareum Holdings (SAR) Price & Analysis

Compare
22 Followers

SAR Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.30%99.70%
Mutual Funds
― Other Institutional Investors
99.70% Public Companies and
Individual Investors

SAR FAQ

What was Sareum Holdings PLC’s price range in the past 12 months?
Sareum Holdings PLC lowest share price was 11.00p and its highest was 38.00p in the past 12 months.
    What is Sareum Holdings PLC’s market cap?
    Sareum Holdings PLC’s market cap is £24.37M.
      When is Sareum Holdings PLC’s upcoming earnings report date?
      Sareum Holdings PLC’s upcoming earnings report date is Oct 27, 2025 which is in 100 days.
        How were Sareum Holdings PLC’s earnings last quarter?
        Currently, no data Available
        Is Sareum Holdings PLC overvalued?
        According to Wall Street analysts Sareum Holdings PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Sareum Holdings PLC pay dividends?
          Sareum Holdings PLC does not currently pay dividends.
          What is Sareum Holdings PLC’s EPS estimate?
          Sareum Holdings PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Sareum Holdings PLC have?
          Sareum Holdings PLC has 135,411,900 shares outstanding.
            What happened to Sareum Holdings PLC’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Sareum Holdings PLC?
            Currently, no hedge funds are holding shares in GB:SAR

            Company Description

            Sareum Holdings PLC

            Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.
            Similar Stocks
            Company
            Price & Change
            Follow
            Futura Medical
            ImmuPharma
            OptiBiotix Health
            Tissue Regenix
            Arecor Therapeutics PLC
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis